We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.67%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$53.7B
AUM Growth
+$5.48B
(+11%)
Cap. Flow
+$3.13B
Cap. Flow
% of AUM
5.82%
Top 10 Holdings %
Top 10 Hldgs %
13.99%
Holding
2,619
New
214
Increased
1,332
Reduced
871
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$676M |
| 2 |
Meta Platforms (Facebook)
META
|
+$158M |
| 3 |
Snap
SNAP
|
+$103M |
| 4 |
Dropbox
DBX
|
+$88.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Nasdaq Bank ETF
FTXO
|
+$607M |
| 2 |
Bankunited
BKU
|
+$98.4M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$73.8M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$73.6M |
| 5 |
EGOV
NIC Inc
EGOV
|
+$71.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 12.61% |
| 3 | Financials | 10.99% |
| 4 | Communication Services | 10.58% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nektar Therapeutics
NKTR
$2.39B
| $126M | 0.23% |
137,927
+87,985
| +176% | +$75.1M |
|
77
Neurocrine Biosciences
NBIX
$17.7B
| $126M | 0.23% |
1,020,857
+41,186
| +4% | +$4.67M |
|
78
Kraft Heinz
KHC
$30.4B
| $125M | 0.23% |
2,275,451
+95,683
| +4% | +$5.72M |
|
|
VG
79
DELISTED
Vonage Holdings Corporation
VG
| $125M | 0.23% |
8,849,440
-75,489
| -0.8% | -$1.04M |
|
|
CSOD
80
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $124M | 0.23% |
2,184,752
+137,316
| +7% | +$7.41M |
|
|
ALXN
81
DELISTED
Alexion Pharmaceuticals
ALXN
| $123M | 0.23% |
884,257
+343,838
| +64% | +$43.1M |
|
|
82
Advanced Micro Devices
AMD
$851B
| $123M | 0.23% |
3,967,231
+3,621,560
| +1,048% | +$81.7M |
|
83
JPMorgan Chase
JPM
$939B
| $122M | 0.23% |
1,082,868
-426,036
| -28% | -$48.4M |
|
84
Acadia Pharmaceuticals
ACAD
$4.25B
| $122M | 0.23% |
5,870,693
+3,267,247
| +125% | +$51.4M |
|
85
Biogen
BIIB
$29.9B
| $121M | 0.22% |
341,459
+85,505
| +33% | +$29.4M |
|
86
BioMarin Pharmaceuticals
BMRN
$11.5B
| $119M | 0.22% |
1,227,500
+523,649
| +74% | +$52.3M |
|
87
Cognizant
CTSH
$21.5B
| $117M | 0.22% |
1,514,852
-312,012
| -17% | -$24.4M |
|
88
Regeneron Pharmaceuticals
REGN
$68.8B
| $117M | 0.22% |
288,480
+100,492
| +53% | +$38.2M |
|
89
Charles River Laboratories
CRL
$10.9B
| $116M | 0.22% |
858,962
+310,975
| +57% | +$38.4M |
|
90
Precigen
PGEN
$1.93B
| $115M | 0.21% |
6,702,226
+3,491,403
| +109% | +$51.9M |
|
|
CELG
91
DELISTED
Celgene Corp
CELG
| $115M | 0.21% |
1,288,017
+606,556
| +89% | +$53.6M |
|
92
Cogent Communications
CCOI
$594M
| $113M | 0.21% |
2,026,730
+175,601
| +9% | +$9.41M |
|
93
AbbVie
ABBV
$458B
| $113M | 0.21% |
1,191,965
-150,164
| -11% | -$14.2M |
|
|
P
94
DELISTED
Pandora Media Inc
P
| $113M | 0.21% |
11,839,118
+145,119
| +1% | +$1.22M |
|
95
PNC Financial Services
PNC
$100B
| $113M | 0.21% |
826,183
-278,711
| -25% | -$39.6M |
|
|
AVTA
96
DELISTED
Avantax, Inc. Common Stock
AVTA
| $111M | 0.21% |
2,766,304
+459,911
| +20% | +$16.7M |
|
97
Ionis Pharmaceuticals
IONS
$9.35B
| $110M | 0.2% |
2,125,724
+1,057,960
| +99% | +$49.7M |
|
98
Seagate
STX
$193B
| $109M | 0.2% |
2,303,709
+480,052
| +26% | +$25.7M |
|
99
Gilead Sciences
GILD
$161B
| $108M | 0.2% |
1,395,339
+415,500
| +42% | +$31.4M |
|
100
Incyte
INCY
$23.5B
| $107M | 0.2% |
1,546,098
+691,111
| +81% | +$47.4M |
|
Similar funds
DAM
First Trust Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, First Trust Advisors held 2,619 positions worth $53.7B, up 11% from $48.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $3.13B of net new capital in Q3 2018, opening 214 new positions and adding to 1,332 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 4,470,114 shares worth $708M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bankunited, an estimated $98.4M trimmed.
- First Trust Advisors's largest Q3 2018 buy was First Trust NYSE Arca Biotechnology Index Fund: 4,470,114 shares worth $708M.
- First Trust Advisors added most to Meta Platforms (Facebook) in Q3 2018, an estimated $158M increase.
- First Trust Advisors's biggest Q3 2018 reduction was Bankunited, cutting an estimated $98.4M.
- First Trust Advisors fully exited First Trust Nasdaq Bank ETF in Q3 2018, selling an estimated $607M.
- First Trust Advisors's ten largest holdings make up 14% of its $53.7B portfolio in Q3 2018.
- First Trust Advisors opened 214 new positions and closed 199 in Q3 2018.
- First Trust Advisors's portfolio value rose 11% quarter-over-quarter to $53.7B.
Based on First Trust Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.